225 related articles for article (PubMed ID: 22716933)
1. P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.
McCaffrey G; Staatz WD; Sanchez-Covarrubias L; Finch JD; Demarco K; Laracuente ML; Ronaldson PT; Davis TP
J Neurochem; 2012 Sep; 122(5):962-75. PubMed ID: 22716933
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac.
Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Zhang Y; Laracuente ML; DeMarco KM; Ronaldson PT; Davis TP
PLoS One; 2014; 9(2):e88516. PubMed ID: 24520393
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein traffics from the nucleus to the plasma membrane in rat brain endothelium during inflammatory pain.
Tome ME; Herndon JM; Schaefer CP; Jacobs LM; Zhang Y; Jarvis CK; Davis TP
J Cereb Blood Flow Metab; 2016 Nov; 36(11):1913-1928. PubMed ID: 27466374
[TBL] [Abstract][Full Text] [Related]
4. Acute pain alters P-glycoprotein-containing protein complexes in rat cerebral microvessels: Implications for P-glycoprotein trafficking.
Tome ME; Jarvis CK; Schaefer CP; Jacobs LM; Herndon JM; Hunn KC; Arkwright NB; Kellohen KL; Mierau PC; Davis TP
J Cereb Blood Flow Metab; 2018 Dec; 38(12):2209-2222. PubMed ID: 30346224
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery.
Davis TP; Sanchez-Covarubias L; Tome ME
Adv Pharmacol; 2014; 71():25-44. PubMed ID: 25307213
[TBL] [Abstract][Full Text] [Related]
6. Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels.
Schaefer CP; Arkwright NB; Jacobs LM; Jarvis CK; Hunn KC; Largent-Milnes TM; Tome ME; Davis TP
PLoS One; 2018; 13(2):e0192340. PubMed ID: 29414996
[TBL] [Abstract][Full Text] [Related]
7. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia.
McCaffrey G; Seelbach MJ; Staatz WD; Nametz N; Quigley C; Campos CR; Brooks TA; Davis TP
J Neurochem; 2008 Sep; 106(6):2395-409. PubMed ID: 18647175
[TBL] [Abstract][Full Text] [Related]
8. Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor.
Hawkins BT; Sykes DB; Miller DS
J Neurosci; 2010 Jan; 30(4):1417-25. PubMed ID: 20107068
[TBL] [Abstract][Full Text] [Related]
9. Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein.
Seelbach MJ; Brooks TA; Egleton RD; Davis TP
J Neurochem; 2007 Sep; 102(5):1677-1690. PubMed ID: 17697052
[TBL] [Abstract][Full Text] [Related]
10. Identification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels.
Tome ME; Schaefer CP; Jacobs LM; Zhang Y; Herndon JM; Matty FO; Davis TP
J Neurochem; 2015 Jul; 134(2):200-10. PubMed ID: 25832806
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C.
Noack A; Noack S; Hoffmann A; Maalouf K; Buettner M; Couraud PO; Romero IA; Weksler B; Alms D; Römermann K; Naim HY; Löscher W
PLoS One; 2014; 9(2):e88154. PubMed ID: 24505408
[TBL] [Abstract][Full Text] [Related]
12. Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain.
Lochhead JJ; McCaffrey G; Sanchez-Covarrubias L; Finch JD; Demarco KM; Quigley CE; Davis TP; Ronaldson PT
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H582-93. PubMed ID: 22081706
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier.
Banks DB; Chan GN; Evans RA; Miller DS; Cannon RE
J Cereb Blood Flow Metab; 2018 May; 38(5):857-868. PubMed ID: 28447863
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins.
Jodoin J; Demeule M; Fenart L; Cecchelli R; Farmer S; Linton KJ; Higgins CF; Béliveau R
J Neurochem; 2003 Nov; 87(4):1010-23. PubMed ID: 14622130
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression.
Huber JD; Witt KA; Hom S; Egleton RD; Mark KS; Davis TP
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1241-8. PubMed ID: 11179069
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Clioquinol on P-glycoprotein Expression and Biometal Distribution in the Mouse Brain Microvasculature.
McInerney MP; Pan Y; Volitakis I; Bush AI; Short JL; Nicolazzo JA
J Pharm Sci; 2019 Jul; 108(7):2247-2255. PubMed ID: 30738852
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier.
Ronaldson PT; Finch JD; Demarco KM; Quigley CE; Davis TP
J Pharmacol Exp Ther; 2011 Mar; 336(3):827-39. PubMed ID: 21131267
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity.
Harati R; Villégier AS; Banks WA; Mabondzo A
J Neuroinflammation; 2012 Dec; 9():273. PubMed ID: 23253775
[TBL] [Abstract][Full Text] [Related]
19. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
Cannon RE; Peart JC; Hawkins BT; Campos CR; Miller DS
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15930-5. PubMed ID: 22949658
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.
Huber JD; Hau VS; Borg L; Campos CR; Egleton RD; Davis TP
Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1531-7. PubMed ID: 12234806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
